Article Versions Notes

Schmitt M, Silva M, Konukiewitz B, Lang C, Steiger K, Halfter K, Engel J, Jank P, Pfarr N, Wilhelm D, et al. Loss of SATB2 Occurs More Frequently Than CDX2 Loss in Colorectal Carcinoma and Identifies Particularly Aggressive Cancers in High-Risk Subgroups. Cancers. 2021; 13(24):6177. https://doi.org/10.3390/cancers13246177

Schmitt, Maxime, Miguel Silva, Björn Konukiewitz, Corinna Lang, Katja Steiger, Kathrin Halfter, Jutta Engel, Paul Jank, Nicole Pfarr, Dirk Wilhelm, and et al. 2021. "Loss of SATB2 Occurs More Frequently Than CDX2 Loss in Colorectal Carcinoma and Identifies Particularly Aggressive Cancers in High-Risk Subgroups" Cancers 13, no. 24: 6177. https://doi.org/10.3390/cancers13246177

Schmitt, M., Silva, M., Konukiewitz, B., Lang, C., Steiger, K., Halfter, K., Engel, J., Jank, P., Pfarr, N., Wilhelm, D., Foersch, S., Denkert, C., Tschurtschenthaler, M., Weichert, W., & Jesinghaus, M. (2021). Loss of SATB2 Occurs More Frequently Than CDX2 Loss in Colorectal Carcinoma and Identifies Particularly Aggressive Cancers in High-Risk Subgroups. Cancers, 13(24), 6177. https://doi.org/10.3390/cancers13246177